SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global COVID-19 pandemic infecting more than 106 million people and causing 2.3 million deaths. The rapid deployment of antibody-based countermeasures has provided hope for curtailing disease and ending the pandemic(1). Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Diamond, Michael, Chen, Rita, Xie, Xuping, Case, James, Zhang, Xianwen, VanBlargan, Laura, Liu, Yang, Liu, Jianying, Errico, John, Winkler, Emma, Suryadevara, Naveenchandra, Tahan, Stephen, Turner, Jackson, Kim, Wooseob, Schmitz, Aaron, Thapa, Mahima, Wang, David, Boon, Andrianus, Pinto, Dora, Presti, Rachel, O’Halloran, Jane, Kim, Alfred, Deepak, Parakkal, Fremont, Daved, Corti, Davide, Virgin, Herbert, Crowe, James, Droit, Lindsay, Ellebedy, Ali, Shi, Pei-Yong, Gilchuk, Pavlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885928/
https://www.ncbi.nlm.nih.gov/pubmed/33594356
http://dx.doi.org/10.21203/rs.3.rs-228079/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885928/
https://www.ncbi.nlm.nih.gov/pubmed/33594356
http://dx.doi.org/10.21203/rs.3.rs-228079/v1

Ejemplares similares